Compare · EAF vs TMO
EAF vs TMO
Side-by-side comparison of GrafTech International Ltd. (EAF) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- EAF operates in Energy, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $257.53B, about 1341.0x EAF ($192.0M).
- TMO has been more active in the news (7 items in the past 4 weeks vs 4 for EAF).
- TMO has more recent analyst coverage (25 ratings vs 6 for EAF).
- Company
- GrafTech International Ltd.
- Thermo Fisher Scientific Inc
- Price
- $7.11-3.07%
- $690.13-0.92%
- Market cap
- $192.0M
- $257.53B
- 1M return
- -
- +4.77%
- 1Y return
- -
- +28.01%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- 2018
- News (4w)
- 4
- 7
- Recent ratings
- 6
- 25
GrafTech International Ltd.
GrafTech International Ltd. researches, develops, manufactures, and sells graphite and carbon based products worldwide. It offers graphite electrodes to produce electric arc furnace steel and other ferrous and non-ferrous metals; and petroleum needle coke, a crystalline form of carbon used in the production of graphite electrodes. The company sells its products primarily through direct sales force, independent sales representatives, and distributors. GrafTech International Ltd. was founded in 1886 and is headquartered in Brooklyn Heights, Ohio.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest EAF
- GrafTech Announces Third Quarter 2026 Earnings Conference Call and Webcast
- SEC Form 4 filed by Director Shivaram Sachin M
- SEC Form 4 filed by Director Germain Jean-Marc
- SEC Form 4 filed by Director Roegner Eric V
- GrafTech and Antora Energy Partner to Power American Industry with Carbon
- GrafTech Announces Graphite Electrode Price Increase
- Chief Financial Officer & SVP O'Donnell Rory F. covered exercise/tax liability with 1,827 shares and converted options into 6,171 shares, increasing direct ownership by 20% to 25,546 units (SEC Form 4)
- GrafTech International Ltd. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities
- GrafTech Announces Planned Closure of Monterrey Graphite Electrode Facility
- SEC Form 10-Q filed by GrafTech International Ltd.
Latest TMO
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- SEC Form 4 filed by Director Keith R. Alexandra
- Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026
- Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development
- Thermo Fisher upgraded by UBS with a new price target
- CLSA initiated coverage on Thermo Fisher with a new price target
- Executive Vice President Shafer Michael D covered exercise/tax liability with 790 shares, decreasing direct ownership by 4% to 20,204 units (SEC Form 4)